SCPHARMACEUTICALS INC (SCPH) Stock Income Statement
NASDAQ:SCPH - Nasdaq - US8106481059 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 41.98M | 36.33M | 13.59M | 0.00 | 0.00 | |||
| Cost Of Goods | 13.05M | 11.36M | 3.81M | N/A | N/A | |||
| Gross Profit | 28.93M | 24.97M | 9.78M | N/A | N/A | |||
| Operating Expenses | 95.61M | 89.75M | 65.18M | 36.16M | 25.82M | |||
| Research and Development | 14.00M | 12.10M | 11.81M | 15.53M | 16.04M | |||
| Selling, General, and Administrative Expenses | 81.61M | 77.65M | 53.37M | 20.62M | 9.78M | |||
| Operating Income | -66.68M | -64.78M | -55.40M | -36.16M | -25.82M | |||
| Interest Income/Expense | -6.48M | -7.33M | -3.02M | -2.10M | -2.53M | |||
| Other Income/Expense | -4.60M | -9.00K | 3.60M | 1.42M | 320.00K | |||
| Non Recurring Items | N/A | -13.03M | N/A | N/A | N/A | |||
| Income Before Taxes | -90.78M | -85.15M | -54.81M | -36.84M | -28.03M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -90.78M | -85.15M | -54.81M | -36.84M | -28.03M | |||
| EBITDA | -66.52M | -64.63M | -54.77M | -36.12M | -25.79M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.91 | -1.91 | -1.42 | -1.30 | -1.14 | |||
| Non GAAP EPS | -1.91 | -1.90 | -1.42 | -1.30 | -1.03 | |||
| Statistics | ||||||||
| Gross Profit Margin | 68.92% | 68.73% | 71.96% | N/A | N/A | |||
| Profit Margin | -216.24% | -234.36% | -403.22% | N/A | N/A | |||
| Operating Profit Margin | -158.82% | -178.29% | -407.53% | N/A | N/A | |||
All data in USD